02/07/2012 07:35:00

Glaxo, Theravance Get Positive Results From LAMA/LABA (UMEC/VI) in COPD

Related content
05 Dec - 
Adaptimmune Announces Initiation of Myxoid/Round Cell L..
02 Feb - 
Adaptimmune and GSK Expand Strategic Immunotherapy Coll..

LONDON--GlaxoSmithKline PLC (GSK.LN) and Theravance, Inc. (THRX) Monday announced positive results from four pivotal phase III studies for once-daily LAMA/LABA (UMEC/VI) in COPD

MAIN FACTS:

-The results of four pivotal phase III studies of investigational LAMA/LABA involving over 4,000 patients with chronic obstructive pulmonary disease.

-These four studies include two 24-week efficacy studies that compared the combination LAMA/LABA, its components and placebo and two 24-week active comparator studies that compared the combination with the LAMA tiotropium, a widely prescribed maintenance bronchodilator for COPD.

-LAMA/LABA is a combination of two investigational bronchodilator molecules - GSK573719 or umeclidinium bromide (UMEC), a long-acting muscarinic antagonist and vilanterol, a long-acting beta2 agonist, administered by a new dry powder inhaler.

-UMEC/VI is a once-daily investigational medicine currently under development for the maintenance treatment of COPD.

-Write to Razak Musah Baba at razak.baba@dowjones.com

(END) Dow Jones Newswires

July 02, 2012 02:35 ET (06:35 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Appointment of Joint Corporate Broker

05/12/2016 15:00:33
Appointment of Joint Corporate Broker Stagecoach Group plc is pleased to announce that RBC Capital Markets has been appointed Joint Corporate Brok..

Rathbones : Form 8.3 - [Alternative Networks PLC]

05/12/2016 12:06:02
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE ..

HSBC Bank Plc : Form 8.5 (EPT/RI) - Brammer PLC

05/12/2016 10:32:18
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Bristol is Open Wins Internet of Things Award for Programmable City Initiative
2
Form 8 (OPD) - Alternative Networks plc
3
The Eye Doctors Host an Event on December 7 to Celebrate the Launch of Their Men’s Premier Red Bull Eyewear Line
4
Form 8.5 (EPT/RI) - Alternative Networks plc - AMENDMENT
5
Karyopharm Presents Updated Phase 1b STOMP Data at the American Society of Hematology 2016 Annual Meeting

Related stock quotes

Glaxosmithkline PLC ORD .. 1,453.00 -0.4% Stock price decreasing
GlaxoSmithKline PLC 37.67 0.0% Stock price unchanged

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2016   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
06 December 2016 10:15:38
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20161205.1 - EUROWEB1 - 2016-12-06 11:15:38 - 2016-12-06 10:15:38 - 1000 - Website: OKAY